0000000001086584

AUTHOR

Pistone Giuseppe

showing 3 related works from this author

Late onset of headache in a patient treated with alitretinoin

2015

AdultMaleTime FactorsDermatologic AgentHand DermatoseTime FactorEczemaHeadacheTretinoinHand DermatosesFollow-Up StudieHumansDermatologic AgentsAlitretinoinFollow-Up StudiesHuman
researchProduct

A Case of Moderate Hidradenitis Suppurativa and Psoriasis Treated with Secukinumab

2018

Hidradenitis suppurativa (HS) is a disorder of the apocrine gland causing a chronic, recurrent and painful inflammation. It is a disabilitating condition and, though many therapeutic options are available, the response is often ineffective in most cases and patients can present many recurrences with physical and psychological sequelae. Recent data had shown increased interleukin (IL)-17 serum levels in patients with HS. Psoriasis is a chronic immune-mediated inflammatory disorder and new evidences have shown the role of Th17 cells in its pathogenesis and the therapeutic efficacy of anti-IL-17 antibodies. We present a case of a patient suffering from psoriasis and HS successfully treated wit…

medicine.medical_specialtybusiness.industryInterleukin-17ApocrineInterleukinCase ReportInflammationDermatologymedicine.diseaseDermatologyPathogenesisHidradenitis suppurativa030207 dermatology & venereal diseases03 medical and health sciences0302 clinical medicine030220 oncology & carcinogenesisPsoriasismedicinePsoriasisHidradenitis suppurativaSecukinumabInterleukin 17medicine.symptombusinessAnnals of Dermatology
researchProduct

Autologous Platelet-Rich Plasma in the treatment of androgenetic alopecia: results of a 54-patient prospective study

2021

The current medical treatments of androgenetic alopecia (AGA) have hardly achieved a satisfying clinical improvement. Biologic regenerative therapies, such as platelet-rich plasma (PRP) injections in the scalp, have been proposed recently. This multidisciplinary prospective study aims to explore the efficacy and safety of autologous PRP injections into the scalp of patients with AGA. Fifty-four patients with AGA (35 men and 19 women) were enrolled. Non-activated autologous PRP was injected into the androgen-related areas of the scalp. The study protocol consisted of three sessions of injections at 3-month interval. The effects were assessed by means of noninvasive methods. Safety profile, p…

MalePlatelet-Rich Plasma Autologous PRP Androgenetic Alopecia Woman AGA Man AGA Growth FactorScalpTreatment OutcomePlatelet-Rich PlasmaSettore MED/35 - Malattie Cutanee E VenereeHumansAlopeciaFemaleProspective StudiesHair
researchProduct